|
atrasentan
atrasentan
information and resources from the National Cancer Institute
atrasentan
An orally available pyrrolidine-3-carboxylic acid with potential antineoplastic activity. As a selective antagonist of the endothelin-A (ETA) receptor, atrasentan binds selectively to the ETA receptor, thereby inhibiting tumor cell proliferation and tumor-associated angiogenesis. atrasentan
An orally available pyrrolidine-3-carboxylic acid with potential antineoplastic activity. As a selective antagonist of the endothelin-A (ETA) receptor, atrasentan binds selectively to the ETA receptor, thereby inhibiting tumor cell proliferation and tumor-associated angiogenesis.
|
|
|
|
|
|
atrasentan
-->
|
